Showing results (261-270 of 274) with videos related to
Sort By:
Pageof 28
Journal for Immunotherapy of Cancer|August 30, 2024
NKG2C/KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastomaOlaya de Dios, M Angeles Ramírez-González, Irene Gómez-Soria, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2018
IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced GlioblastomaErik Ladomersky, Lijie Zhai, Alicia Lenzen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2021
Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in GlioblastomaLijie Zhai, April Bell, Erik Ladomersky, et al.Journal for Immunotherapy of Cancer|July 28, 2022
Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitryTeresa T Nguyen, Dong Ho Shin, Sagar Sohoni, et al.Brain, Behavior, & Immunity - Health|April 11, 2024
Age-stratified comorbid and pharmacologic analysis of patients with glioblastomaErik E Rabin, Jonathan Huang, Miri Kim, et al.Cell Reports|November 3, 2021
Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drugJunfeng Bi, Atif Khan, Jun Tang, et al.Biorxiv : the Preprint Server for Biology|January 20, 2025
Rational Design and Optimization of a Potent IDO1 Proteolysis Targeting Chimera (PROTAC)Paige J Monsen, Prashant V Bommi, Arabela A Grigorescu, et al.Journal of Medicinal Chemistry|February 13, 2025
Rational Design and Optimization of a Potent IDO1 Proteolysis Targeting Chimera (PROTAC)Paige J Monsen, Prashant V Bommi, Arabela A Grigorescu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with GlioblastomaErik Ladomersky, Lijie Zhai, Kristen L Lauing, et al.Journal of Medicinal Chemistry|November 21, 2022
Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for GlioblastomaLakshmi R Bollu, Prashant V Bommi, Paige J Monsen, et al.Pageof 28